PCSK9-neutralizing monoclonal antibodies
1 finding
What did studies of PCSK9-neutralizing monoclonal antibodies find?
1Studies of PCSK9-neutralizing monoclonal antibodies measured one outcome, atherosclerotic cardiovascular disease.
Atherosclerotic cardiovascular disease
downin reviews1
1 study
Atherosclerotic cardiovascular disease
downin reviews1
PCSK9-neutralizing monoclonal antibodies decrease atherosclerotic cardiovascular disease.
“Monoclonal antibodies that neutralize circulating PCSK9 have demonstrated the utility of PCSK9 inhibition for reducing LDL-C and ASCVD.”
Review
In-vivo CRISPR/Base-Editing "One-Shot" Therapies Targeting PCSK9
Current atherosclerosis reports